R Clavero|F Ramos|J Martí - JoVE Visualize

Showing results (301-310 of 1,023) with videos related to

Pageof 103

Sort By:

European Urology|November 6, 1998

Balloon dilatation in the treatment of ureteral stenosis in kidney transplant recipientsA Collado, J Caparrós, L Guirado, et al.

Revista Espanola De Enfermedades Digestivas|August 1, 1996

[Options in the surgical treatment of diffuse cavernous hemangioma of the rectum]J Castellví, D Pares, E Ramos, et al.

Bioresource Technology|June 28, 2014

Improvement through low cost biofilm carrier in anaerobic tubular digestion in cold climate regionsJ Martí-Herrero, R Alvarez, M R Rojas, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1993

[Thyroid lymphoma in a 51-year-old woman]M T Herranz, A Corrales, M A Molina, et al.

Foods (Basel, Switzerland)|July 14, 2023

Enhancing Nutrient Recovery and Bioactive Compound Extraction from Spirulina through Supercritical Fluid Extraction: Implications for SH-SY5Y Cell ViabilityFrancisco J Martí-Quijal, Noelia Pallarés, Katarzyna Dawidowicz, et al.

Journal of Cellular Physiology|October 18, 2006

Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissuesHongjuan Zhao, Cristiane F Ramos, James D Brooks, et al.

Revista Espanola De Anestesiologia Y Reanimacion|February 1, 1995

[Selection and maintenance of lung donors]J V Llau, R Vicente, F Ramos, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serumO F Ramos, G Sármay, E Klein, et al.

European Journal of Immunology|July 1, 1987

Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragmentsG Sármay, O F Ramos, E Klein, et al.

Immunobiology|December 1, 1983

The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytesO F Ramos, M G Masucci, M T Bejarano, et al.

Pageof 103

Showing results (301-310 of 1,023) with videos related to

Sort By:

Pageof 103

European Urology|November 6, 1998

Balloon dilatation in the treatment of ureteral stenosis in kidney transplant recipientsA Collado, J Caparrós, L Guirado, et al.

Revista Espanola De Enfermedades Digestivas|August 1, 1996

[Options in the surgical treatment of diffuse cavernous hemangioma of the rectum]J Castellví, D Pares, E Ramos, et al.

Bioresource Technology|June 28, 2014

Improvement through low cost biofilm carrier in anaerobic tubular digestion in cold climate regionsJ Martí-Herrero, R Alvarez, M R Rojas, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1993

[Thyroid lymphoma in a 51-year-old woman]M T Herranz, A Corrales, M A Molina, et al.

Foods (Basel, Switzerland)|July 14, 2023

Enhancing Nutrient Recovery and Bioactive Compound Extraction from Spirulina through Supercritical Fluid Extraction: Implications for SH-SY5Y Cell ViabilityFrancisco J Martí-Quijal, Noelia Pallarés, Katarzyna Dawidowicz, et al.

Journal of Cellular Physiology|October 18, 2006

Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissuesHongjuan Zhao, Cristiane F Ramos, James D Brooks, et al.

Revista Espanola De Anestesiologia Y Reanimacion|February 1, 1995

[Selection and maintenance of lung donors]J V Llau, R Vicente, F Ramos, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serumO F Ramos, G Sármay, E Klein, et al.

European Journal of Immunology|July 1, 1987

Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragmentsG Sármay, O F Ramos, E Klein, et al.

Immunobiology|December 1, 1983

The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytesO F Ramos, M G Masucci, M T Bejarano, et al.

Pageof 103